Back to AZN Stock Lookup

AstraZeneca (AZN) –

May 3, 2016 03:12 PM AstraZeneca (AZN) Says North America Commercial Business HQ Will Remain in Delaware
May 3, 2016 11:58 AM Form 6-K ASTRAZENECA PLC For: May 03
May 3, 2016 08:28 AM Form 6-K ASTRAZENECA PLC For: May 03
May 3, 2016 08:26 AM Form 6-K ASTRAZENECA PLC For: May 03
Apr 29, 2016 01:13 PM Form 6-K ASTRAZENECA PLC For: Apr 29
Apr 29, 2016 12:51 PM UPDATE: FDA Approves First Generic Crestor (AZN)
Apr 29, 2016 12:32 PM UPDATE: AstraZeneca (AZN), Novartis (NVS),Pfizer (PFE) Said Among Firms Weighing Bids for Medivation (MDVN)
Apr 29, 2016 08:30 AM Form 6-K ASTRAZENECA PLC For: Apr 29
Apr 29, 2016 07:53 AM AstraZeneca (AZN) Receives Positive EMA CHMP Opinion on Zavicefta as cIAI, cUTI, and HAP Treatment
Apr 29, 2016 07:50 AM AstraZeneca (AZN) Tops Q1 EPS by 2c; Offers FY16 Outlook
Apr 29, 2016 07:40 AM Form 6-K ASTRAZENECA PLC For: Apr 29
Apr 28, 2016 10:54 AM Form 6-K ASTRAZENECA PLC For: Apr 28
Apr 26, 2016 08:09 AM Form 6-K ASTRAZENECA PLC For: Apr 26
Apr 26, 2016 07:41 AM AstraZeneca (AZN) Announces FDA Approval of Bevespi Aerosphere for COPD
Apr 26, 2016 07:39 AM Form 6-K ASTRAZENECA PLC For: Apr 26
Apr 25, 2016 07:36 PM BEVESPI AEROSPHERE(TM) Approved by the US FDA for Patients With COPD
Apr 25, 2016 07:50 AM Medivation (MDVN) Only Worth $55 To $70 in a Deal - Leerink
Apr 21, 2016 09:15 AM TapImmune Announces Phase 2 Ovarian Cancer Trial Study with AstraZeneca/MedImmune and Sloan Kettering Cancer Institute
Apr 18, 2016 08:30 AM Second Annual Regional BioTech Forum Brings Industry, Academia, Government Together to Raise Region’s Prominence as Top Biotech Hub
Apr 18, 2016 07:14 AM AstraZeneca (AZN) Considering Offer for Medivation (MDVN) - Times
Apr 18, 2016 06:19 AM AstraZeneca (AZN) Will Present DNA Damage Response Pipeline Data at AACR 2016
Apr 18, 2016 02:00 AM AstraZeneca Presents DNA Damage Response Science at the AACR 2016 Annual Meeting
Apr 12, 2016 10:32 AM Notable Analyst Rating Changes 4/12: (CHK) (YNDX) (HLX) Upgraded; (AZN) (SBUX) (LB) Downgraded
Apr 12, 2016 07:59 AM Goldman Sachs Downgrades AstraZeneca (AZN) to Sell
Apr 8, 2016 08:11 AM Form 6-K ASTRAZENECA PLC For: Apr 08
Apr 8, 2016 07:30 AM Allergan Reinforces Commitment to Anti-Infective Innovation with 20 Abstracts Highlighted at ECCMID 2016
Apr 8, 2016 05:59 AM AstraZeneca (AZN), Lilly (LLY) Wil lAdvance AZD3293 into Phase 3
Apr 5, 2016 01:55 PM Exclusive: Pfizer leaning toward abandoning deal with Allergan - source
Apr 1, 2016 08:53 AM Form 6-K ASTRAZENECA PLC For: Apr 01
Mar 31, 2016 08:00 AM BRILINTA Preferred Over clopidogrel In Updated American College of Cardiology and American Heart Association Guideline in Acute Coronary Syndrome
Mar 30, 2016 04:30 PM Medivation (MDVN) Said to Work with Bankers to Defend Against Takeover (SNY)
Mar 29, 2016 08:09 AM Inovio Pharma (INO) Updates on INO-3112 HPV Plans; EORTC Trial Study Will Not Move Forward (AZN)
Mar 29, 2016 07:17 AM Advaxis (ADXS) Announces Completion of First Dose-Escalation for AXAL + Durvalumab Combo in HPV-Associated Cancers
Mar 29, 2016 06:39 AM Form 6-K ASTRAZENECA PLC For: Mar 29
Mar 24, 2016 12:15 PM Form 6-K ASTRAZENECA PLC For: Mar 24
Mar 23, 2016 02:32 PM Sanofi (SNY) Considering Takeover of Medivation (MDVN) - Source
Mar 23, 2016 07:14 AM AstraZeneca (AZN) Announces Brilinta/Brilique SOCRATES Trial Missed Primary Endpoint
Mar 23, 2016 07:12 AM Form 6-K ASTRAZENECA PLC For: Mar 23
Mar 22, 2016 08:05 AM Medivation (MDVN) Rumors Mentioned in Daily Mail
Mar 18, 2016 08:24 AM Form 6-K ASTRAZENECA PLC For: Mar 18
Mar 18, 2016 07:04 AM Form 6-K ASTRAZENECA PLC For: Mar 18
Mar 15, 2016 06:56 AM Jefferies Downgrades AstraZeneca (AZN) to Hold
Mar 8, 2016 02:08 PM Form 6-K ASTRAZENECA PLC For: Mar 08
Mar 8, 2016 12:53 PM Form 6-K ASTRAZENECA PLC For: Mar 08
Mar 7, 2016 08:43 AM MedImmune Receives FDA Fast-Track Designation for MEDI8852 (AZN)
Mar 2, 2016 06:57 PM FDA Approves New Indication for FASLODEX® (fulvestrant)
Mar 1, 2016 11:32 AM Form 6-K ASTRAZENECA PLC For: Mar 01
Feb 29, 2016 11:20 AM AstraZeneca (AZN) Announces Tremelimumab Monotherapy Phase 2b Missed Primary Endpoint in Malignant Mesothelioma
Feb 29, 2016 10:35 AM Form 6-K ASTRAZENECA PLC For: Feb 29
Feb 29, 2016 08:17 AM AstraZeneca (AZN) Enters Licensing Agreement for Plendil in China

Back to AZN Stock Lookup